The Utilization of Triton X-100 for Enhanced Two-Dimensional Liquid-Phase Proteomics by Kim, Mina et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2011, Article ID 213643, 7 pages
doi:10.1155/2011/213643
Research Article
The Utilization of Triton X-100 for EnhancedTwo-Dimensional
Liquid-Phase Proteomics
Mina Kim,1 Sang-HeeLee,1 Jiho Min,2 FumihisaKobayashi,3 Hyun-Ju Um,1
and Yang-Hoon Kim1
1Department of Microbiology, Chungbuk National University, 410 Sungbong-Ro, Heungduk-Gu,
Cheongju 361-763, Republic of Korea
2Department of Chemical Engineering, Chonbuk National University, 664-14, 1-Ga, Duckjin-Dong, Duckjin-Gu,
Jeonju 561-156, Republic of Korea
3School of Natural System, College of Science and Engineering, Kanazawa University, Kakuma-Machi, Kanazawa,
Ishikawa 920-1192, Japan
Correspondence should be addressed to Hyun-Ju Um, hjtptkd@chungbuk.ac.kr and Yang-Hoon Kim, kyh@chungbuk.ac.kr
Received 16 May 2011; Revised 8 August 2011; Accepted 9 August 2011
Academic Editor: J. R. Botella
Copyright © 2011 Mina Kim et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
One of the main challenges in proteomics lies in obtaining a high level of reproducible fractionation of the protein samples.
Automated two-dimensional liquid phase fractionation (PF2D) system manufactured by Beckman Coulter provides a process well
suited for proteome studies. However, the protein recovery eﬃciency of such system is low when a protocol recommended by the
manufacturer is used for metaproteome proﬁling of environmental sample. In search of an alternative method that can overcome
existing limitations, this study replaced manufacturer’s buﬀers with Triton X-100 during the PF2D evaluation of Escherichia coli
K12. Three diﬀerent Triton X-100 concentrations—0.1%, 0.15%, and 0.2%—were used for the ﬁrst-dimension protein proﬁling.
As the ﬁrst-dimension result was at its best in the presence of 0.15% Triton X-100, second-dimension protein fractionation was
performed using 0.15% Triton X-100 and the standard buﬀers. When 0.15% Triton X-100 was used, protein recovery increased
as much as tenfold. The elution reliability of 0.15% Triton X-100 determined with ribonuclease A, insulin, α-lactalbumin, trypsin
inhibitor, and cholecystokinin (CCK) aﬃrmed Triton X-100 at 15% can outperform the standard buﬀers without having adverse
eﬀects on samples. This novel use of 0.15% Triton X-100 for PF2D can lead to greater research possibilities in the ﬁeld of
proteomics.
1.Introduction
The development of analytical tools for rapid analysis and
identiﬁcation of expressed protein proﬁles in cell, tissue or
organism is currently an important area in biological re-
search [1–3]. Although two-dimensional gel electrophoresis
(2DE)isaclassicaltechniquethatmonitorsanddistinguishes
multiple forms of proteins with diﬀerences in molecular
mass or pI values, it can face diﬃculties with proteins of
e x tr e m em a s s( e . g. ,>200kDa or <10kDa) or pI values [4–6].
In addition, 2DE is not readily amenable to automation.
Liquid-phase separation methods such as size-exclusion
chromatography,aﬃnitychromatography,andion-exchange
chromatography exhibited practical diﬃculties due to
the lack of the isoelectric (pI) information and limited label-
ing eﬃciency [7–9]. Alternatively, the ProteomeLab PF2D
platform (Beckman Coulter, USA) that can be used for the
separation/fractionation, as well as quantitative comparisons
of various biological and clinical samples, works in full
automation combining chromatofocusing separation and
hydrophobic fractionation [10]. During the ﬁrst-dimension
chromatofocusing of PF2D, proteins areseparated bytheirpI
andseparatedproteinswithapHgradientarecollectedusing
afractioncollector[11,12].Subsequently,fractionscollected
from the ﬁrst dimension are separated using reversed phase
chromatography in the second dimension, which separates
on the basis of hydrophobicity [12]. Separated fractions
are monitored with UV detection to observe changes in2 Journal of Biomedicine and Biotechnology
the proteome [13–15]. Then, the selected peak can be
identiﬁed by mass spectrometry. Although PF2D system
oﬀers high loading capacity and improved detection limit
with lower abundance proteins [16, 17], its protein recovery
eﬃciencyduringthechromatofocusingstepwillbelowwhen
the standard protocol recommended by the manufacturer is
u s e d .S h e n ge ta l .[ 18] reported that the inclusion of 20%
isopropanol in the isoelectric focusing (IEF) buﬀer increased
the number of proteins they could identify in the serum.
They demonstrated improved recovery of protein, but puri-
ﬁed BSA was used instead of complete serum. This buﬀer’s
ability to improve the recovery of all proteins thus remains
unclear.
The columns used with PF2D require the use of nonionic
detergents such as Triton X-100 for the separation of prot-
eins. Triton X-100 is a low-cost mixture of octylphenol etho-
xylates, with an average of about 9-10 ethylene oxide units
per molecule. In search of an alternative method that can in-
crease the recovery of a wide range of proteins, this study
modiﬁed the standard protocol using Triton X-100. Buﬀers
recommended by Beckman Coulter’s ProteomeLab PF2D
protocol was replaced by Triton X-100 during protein pro-
ﬁling of Escherichia coli K12, in which its recovery eﬃciency
was determined at various Triton X-100 concentrations.
Sub-sequently, the elution accuracy of Triton X-100 at its
optimized condition was conﬁrmed by the control protein
mixture of ribonuclease A, insulin, α-lactalbumin, trypsin
inhi-bitor, and cholecystokinin (CCK).
2.MaterialsandMethods
2.1. Sample Preparation. The eligibility of Triton X-100 as
a replace-ment for buﬀers used for ProteomeLab protein
liquid chromatography was determined with Escherichia coli
K12 substrain W3110 and control mixture of proteins (ribo-
nuclease A, insulin, α-lactalbumin, trypsin inhibitor, and
cholecystokinin (CCK)). E. coli K12 was cultivated at 37◦C
in 200mL LB medium (1% Bacto tryptone, 0.5% Bacto yeast
extract, 0.5% NaCl, pH 7.2), to an OD600 of 1.5. The cells
were harvested by centrifugation at 6000×gf o r1 0 m i na t
4◦C and washed in 10mM Tris-HCl buﬀer (pH 8.0). After
being resuspended in 10mL of ice-cold lysis buﬀer (7M
urea, 2M thiourea, 4% 3-[(3-cholamidopropyl) dimethy-
lammonio]-1-propanesulfonate (CHAPS), 65mM dithio-
threitol (DTT), 1.25mM protease inhibitor), cells were soni-
cated on ice 30 times for 10s each. Obtained cell lysates were
centrifuged at 6000×gf o r1 0m i na t4 ◦C, and the ﬁnal pro-
tein concentration in the supernatant was determined using
the Bradford protein assay (BioRad, USA). 3.0mg protein
aliquots were stored at −70◦C until the next use. Proteome-
Lab PF2D Protein Test Mix, which included 5 proteins
(ribonuclease A, insulin, α-lactalbumin, trypsin inhibitor,
and cholecystokinin (CCK)), was purchased from Beckman
Coulter (CA, USA).
2.2. Liquid Chromatography. Before the chromatofocusing,
cell extracts were exchanged to various start buﬀers using
a PD-10 column (GE Healthcare Life Sciences, USA), and
the ﬁrst 3.5mL fraction was collected. While the start buﬀer
included in the ProteomeLab kit was designated as the “Start
Buﬀer A,” “Start Buﬀer B, C, and D” were prepared with the
following: 0.1%, 0.15%, and 0.2% Triton X-100 in distilled
water (EMD Chemicals, Inc., USA) at pH 8.4 for “B,” “C,”
and“D , ”respectively;6Murea;25mMBis-T ris;1Mammo-
nium hydroxide. Protein concentration was estimated using
Quant-iT Protein Assay Kits (Invitrogen, USA). All samples
were diluted with each start buﬀer to obtain a ﬁnal protein
concentration of 1.5mg/mL, and 2mL of E. coli protein
was injected into the chromatofocusing column. All protein
samples were ﬁltered through 0.2μmP E SM e m b r a n eﬁ l t e r s
(Millipore, USA). The chromatofocusing was performed
using the ProteomeLab PF2D (Beckman-Coulter, USA) with
an HPCF-1D column (250mm × 2.1mm, Eprogen, USA)
that was loaded with each starting buﬀer (pH 8.5 ± 0.1)
for 120min. Each starting buﬀer was then equilibrated to
the initial pH 8.5, and protein sample was loaded at a ﬂow
rate of 0.2mL/min for 45min. The protein sample elution
was initiated with a linear gradient of various elution buﬀers
(pH 4.0 ± 0.1) that took ∼60min to complete. Eluent buﬀer
included in the ProteomeLab kit was labeled as “Eluent
BuﬀerA.”“EluentBuﬀerB,C,andD”werepreparedwiththe
following: 0.1%, 0.15%, and 0.2% Triton X-100 in distilled
water at pH 4.0, respectively; iminodiacetic acid; 6M urea;
10% v/v polybuﬀer 74 (GE Healthcare, USA). Proteins were
eluted and collected by their isoelectric point (pI) in 4.0–8.5
range with 0.2pH intervals into a 96-deep-plate well using
the FC/I module. Remaining protein samples were ﬁnally
elutedbywashingthecolumnwith1MNaClfor40min.The
column was then rinsed with 10 column volumes of distilled
water before the next sample injection. The entire chro-
matofocusing step was operated at 20◦Cw i t haﬂ o wr a t eo f
0.2mL/min, and elution proﬁles were monitored at 280nm
by Beckman 166UV detector (Beckman Coulter, USA).
And the second-dimension separation was performed using
HPRP column (33mm × 4.6mm, 1.5μmn o n p o r o u sO D S -
IIIE C18 silica beads, Eprogen, USA) at 50◦Cwi t haﬂ o wr a t e
of 0.75mL/min. A 200μL from the ﬁrst chromato-focusing
fraction was injected into the column and eluted with
a 0–100% linear gradient of solvent A (0.1% w/v TFA in
distilledwater)andsolventB(0.08%w/vTFAinacetonitrile)
for 35min. At the end of second-dimension run, the
column was equilibrated with an initial mobile phase for
10 column volumes. Proteins were detected by a Beckman
166UVdetector(BeckmanCoulter,USA)at214nm.Protein
proﬁles obtained using UV detection were analyzed by Pro-
teoVue 2D (Beckman Coulter, USA).
2.3. Determining Elution Reliability of 0.15% Triton X-100
during PF2D. To investigate the elution accuracy of 0.15%
Triton X-100, the mixture of ﬁve proteins purchased from
Beckman Coulter (USA) was injected into the HPCF-1D
column that allows the elution of proteins in pH range of
4.0–8.5.Theﬁrst-andsecond-dimensionproteinseparations
were achieved following the standard procedure described in
Section 2.2 using Start Buﬀer C (pH 8.4) and Eluent Buﬀer
C (pH 4.0). Protein proﬁle data obtained using UV detectionJournal of Biomedicine and Biotechnology 3
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Figure 1: First-dimension elution proﬁles of E. coli K12 chromatofocusing analyzed on Beckman Coulter’s PF2D system over 200min using
the buﬀer provided by the manufacture (A) or buﬀers prepared with Triton X-100 of various concentrations (0.1, 0.15, or 0.2% for B, C, and
D, resp.). The elution proﬁles were monitored at 280nm.
were collected and analyzed by ProteoVue 2D software
(Beckman Coulter, CA, USA).
3. Results andDiscussion
3.1. The Use of Triton X-100 for PF2D Chromatofocusing of
E. coli. The eligibility and eﬃciency of Triton X-100 as an
alternative to the buﬀers suggested for ProteomeLab (Beck-
man Coulter, California, USA) PF2D were evaluated with
E.coli,usingthestandardProteomeLabbuﬀeraswellassolu-
tions prepared with 0.1%, 0.15%, and 0.2% Triton X-100.
The ﬁrst-dimension chromatofocusing separates proteins to
diﬀerences in pI values, and the absorbance proﬁles created
by each solution are shown in Figure 1. Proteins were eluted
in the order of decreasing pI values, and all four solutions
eluted its ﬁrst peak during the ﬁrst 20min of sample loading
period. As the HPCF-1D column used in this study provides
limitedelutioneﬃciencywithproteinswhosepI valuesarein
8.5–4.0 range, the ﬁrst peak corresponds to protein unbound
to HPCF-1D column because of its pI value being greater
than 8.5. The details of protein separation and pH gradient
formation varied among four solutions. At ﬁrst, E. coli
chromatofocusing was performed using the buﬀer suggested
for Beckman Coulter’s ProteomeLab platform. As shown in
Figure 1(a), ﬁrst unbound protein was eluted during the
ﬁrst ∼20min,andthepHgradientstartedformingat50min.
The pH gradient which started forming at 50min (from pH
8.1) lasted until 105min (to pH 3.5), with a slight downward
angle created at 92min. During the pH gradient well-
deﬁned, multiple protein peaks were observed. Acidic pro-
teins which remained in HPCF-1D column were eluted after
130min as a result of washing the column with 1M NaCl.
Under given conditions, Beckman Coulter’s standard buﬀer
provided a well-deﬁned protein chromatofocusing results in
high resolution.
Alternatively, solutions which included 0.1%, 0.15%, and
0.2% Triton X-100 were prepared and used in place of stan-
dard buﬀers to perform ﬁrst-dimension protein proﬁling of
E. coli. When the solution that included 0.1% Triton X-
100 was used the ﬁrst protein peak created in ∼20min was
inverted, giving a negative AU280 reading (Figure 1(b)). This
peak was followed by another inverted peak that was created
during 48–58min. When pH gradient formed during 50–
130min, proteins of low pI values (5.0 >p I )w e r ee l u t e d4 Journal of Biomedicine and Biotechnology
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Figure 2: Second-dimension separations of 16 ﬁrst-dimension fractions which were generated with Beckman Coulter buﬀer over pH 7.92–
3.95 (a) and 0.15% Triton X-100 over pH 7.74–3.95 (b). The 2D fraction proﬁles were monitored at 214nm and eluted in the order of
increasing hydrophobicity.
indistinctively. After 130min, remnant protein in HPCF-
1D column was eluted with column washing and created a
large peak area. Subsequently, the concentration of Triton X-
100 was increased to 0.15%. Figure 1(c) of 0.15% Triton X-
100 showed signiﬁcantly improved protein proﬁling results:
anunboundproteinwaselutedat<20min,smallamountsof
proteins were eluted during 20–60min (pH 8.5–7.74) while
the sample was being loaded, and a pH gradient was created
during 60–110min (pH 7.74–3.95). Unlike 0.1% Triton X-
100, 0.15% Triton X-100 created a linear pH gradient,Journal of Biomedicine and Biotechnology 5
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Figure 3: PF2D results of Beckman Coulter’s protein test mixture containing ﬁve proteins (Ribonuclease A, insulin, α-lactalbumin, trypsin
inhibitor, cholecystokinin (CCK)). (A) First-dimension elution proﬁle of ﬁve proteins generated using 0.15% Triton X-100 over 200min.
The elution proﬁles were monitored at 280nm. (B) ProteoVue 2D map of ﬁve proteins having pI 8.15–4.00 eluted in the order of increasing
hydrophobicity. The fraction proﬁles were monitored at 214nm.
an indication that the capacity is even throughout its pH
range. Chromatofocusing that took place over the pH gradi-
ent is also sharp. As with other solutions, a large protein peak
appeared at 160min. Finally, 0.2% Triton X-100 was used to
determine whether increasing the concentration of Triton
X-100 would bring further improvements for chromatofo-
cusing of E. coli. Interestingly, after the ﬁrst unbound protein
was eluted at <20min, no signiﬁcant protein elution was
observed until the start of the pH gradient at 50min
(Figure 1(d)). As the pH gradient for 0.2% Triton X-100 was
created over the shortest time frame (during 50–80min, pH
7.11–3.89), a high volume of proteins were eluted abruptly
during pH gradient thus creating unreliable proﬁling data
(Figure 1(d)).
The performance of each buﬀer was judged upon its
ability to achieve a well-deﬁned pH gradient as well as an
accurate pI-based protein separation at a given pH gradient
range. Indistinct chromatofocusing results and negative
AU280 readings made 0.1% Triton X-100 inadequate for
PF2D. While the performance of 0.15% Triton X-100 was
comparable to that of standard buﬀers suggested for Pro-
teomeLab PF2D, 0.2% Triton X-100 created a protein proﬁle
whose pI v a l u e sw e r ed u b i o u sa si th a p p e n e di nas h o r t e r
time frame. However, AU280 readings of 0.15% and 0.2%
Triton X-100 were as much as 9-10 times higher than those
of Beckman Coulter’s. Such high AU280 readings obtained
using 0.15% Triton X-100 were investigated further during
the second-dimension separation that was performed on 166 Journal of Biomedicine and Biotechnology
Table 1:ThesummaryofexperimentalandtheoreticalpI intervalsofﬁveproteinsincludedinproteintestmixturepurchasedfromBeckman
Coulter.
Lane no.a Protein bandb Protein MW (Da) Theoretical pI interval Experimental pI intervalc
2 A CCK (cholecystokinin) 1055 <4.00 4.02–4.04
4 B Trypsin inhibitor 20100 4.00–4.60 4.12–4.42
5C α-Lactalbumin 14200 4.50–5.20 4.42–4.72
10 D Insulin 5808 5.90–6.60 5.74–6.04
18 E Ribonuclease A 5500 >8.50 8.00–8.10
a,b,cRefer to Figure 3(b).
ﬁrst-dimension protein fractions generated using the stan-
dard and 0.15% Triton X-100 solution. Second-dimension
of PF2D fractionates in the order of increasing hydropho-
bicity. As shown in Figure 2(a),1 6p r o t e i nf r a c t i o n si np H
7.92–3.95obtainedusingBeckmanCoulterbuﬀerswerefrac-
tionized, and a thick protein band indicating a large quantity
of proteins was seen around pH 5.01–4.70. The second-
dimension result of 0.15% Triton X-100 that began from 16
ﬁrst-dimension fractions (pH 7.74–3.95) showed distinctive
bands for wider pI ranges. This novel methodology that
utilizes 0.15% Triton X-100 enhances protein recovery
eﬃciency by at least tenfold.
3.2. Reliability Test Results of 0.15% Triton X-100. First- and
second-dimension chromatography results shown in this
study conﬁrmed protein recovery can be increased in the
presenceof15%TritonX-100duringPF2DanalysisofE.coli,
but its reliability with regard to accurate pI separation is yet
tobejudgedwithoutcomparingtheresultswiththestandard
proteins whose pI values are known. Once again, the elution
proﬁles of ﬁve-protein test mixture (Ribonuclease A, insulin,
α-lactalbumin, trypsin inhibitor, cholecystokinin (CCK))
were generated using 0.15% Triton X-100 (Figure 3(a)). The
linear pH gradient was observed during 52–108min, from
pH 8.2–4.1. Multiple peaks were eluted in high resolution
during its pH gradient. The accuracy of such protein elution
was to be determined using the second-dimension protein
chromatogram with a mixture of 5 proteins whose theoreti-
cal pI values are known (Figure 3(b)). The theoretical pI
valueofribonucleaseAis pI > 8.5buttheactualelutiontook
over pI 8.1-8.0 (shown with the protein band E in
Figure 3(b)), possibly due to a limited pH elution range set
by the HPCF-1D column. The elution intervals of insulin,
α-lac-talbumin, trypsin inhibitor, and CCK (shown by pro-
tein bands D, C, B, and A, resp.) were similar to their theo-
retical ranges. The detailed comparison of the experimental
elution intervals of ﬁve control proteins with regard to
theoretical values is summarized in Table 1.
4. Conclusion
Triton X-100 is a common nonionic surfactant, and the
experimental results of this study aﬃrmed that 0.15% Triton
X-100 can be applied towards PF2D of a protein. Not only
can 0.15% Triton X-100 greatly increase amount of protein
recovery from chromatofocusing column, but it also enables
PF2D analysis of protein with low pI. Combining the bene-
ﬁcial qualities mentioned thus far, 0.15% Triton X-100 for
PF2D system can be exploited for further analyses of meta-
proteome originating from various sources.
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